Purpose: To investigate the relationship between diabetes self-care behavior and cognitive function of hospitalized young and middle-aged Chinese patients with type 2 diabetes mellitus (T2DM). Patients and Methods: In this cross-sectional study, young and middle-aged T2DM patients (age range, 35– 65 years) were recruited at 4 tertiary hospitals between July 2016 and January 2017. Data pertaining to self-care behavior and cognitive function were collected using two questionnaires (the Summary of Diabetes Self-care Activities [SDSCA] and the Montreal Cognitive Assessment [MoCA], respectively). Multivariate linear regression analysis was performed to assess the correlation between cognitive function and self-care activities. Results: A total of 140 patients with diabetes were enrolled (mean age, 53.79± 7.96 years). The mean duration of T2DM was 10.83± 6.76 years. Regarding SDSCA performance, the mean scores for foot care and blood glucose monitoring were 2.20± 2.57 and 1.98± 2.45, respectively, which were the worst; scores for exercise (4.01± 2.58) and diet (3.16± 1.89) were better, while scores for medication administration (5.26± 2.79) were the best. The prevalence of cognitive impairment was 37.9% (53 patients). After variables adjustment, delayed recall showed a significant correlation with blood sugar monitoring behavior (B =0.224, P=0.019); visual space and executive function (B=0.255, P=0.009) and abstraction (B=− 0.337, P=0.001) showed a correlation with foot care behavior. Conclusion: Cognitive ability affects the self-care behavior of patients with T2DM. Assessment of cognitive function may help inform patient education interventions to improve the self-care behavior of these patients.
Previous studies have demonstrated that eating time and habits play key roles in human health. However, there is a paucity of research on the epidemiology of eating window and eating habits in China. This study aimed to investigate the relationship between eating window and eating habits among adults in mainland China and explore the factors influencing these parameters. Cross-sectional study. A questionnaire comprising demographic data, metabolic index, eating window and eating habits was administered via the Internet. 1596 adults from mainland China. Eating window of all participants was 13.03 ± 2.02 h (mean ± standard deviation [SD]), which was longer than previously reported in smaller more controlled studies from China. Area of residence and occupation were significant factors influencing eating window after controlling for other factors (area of residence: β, −0.499; 95% confidence interval [CI], −0.897 to −0.101, p = 0.014; occupation: β, −0.309, 95% CI, −0.496 to −0.121, p = 0.001). Participants typically commenced eating at 08:00 h (interquartile range [IQR]: 8:00–9:00) and ceased eating at 20:00 h (IQR: 20:00–22:00). Regular meals which mean two or three meals per day regularly constituted the dominant eating pattern of participants (n = 1233, 77.3%) and 819 (51.1%) participants preferred cooking for themselves. This study revealed that eating window of adults in China generally around 13 h. Area of residence and occupation were the main factors influencing eating window. Our data provide a foundation for future studies on eating window and eating habits in China.
Time-restricted eating (TRE) is a newly emerging dietary strategy that reduces body weight and improves glucose tolerance in individuals with overweight or obesity. However, whether TRE is effective in improving glycemic control in individuals with diabetes remains unexplored. Herein, we aimed to investigate the effects of TRE intervention on glycemic control in patients with type 2 diabetes. In this single-center, open-label, self-controlled trial, 18 overweight or obese adults with type 2 diabetes inadequately controlled on lifestyle modification alone or in combination with metformin and/or α-glycosidase inhibitors were enrolled to receive a 10-h TRE for 12 weeks. The effects of TRE on glucose metabolism, body weight, body composition and other metabolic parameters were evaluated in these participants following the intervention. The 12-week TRE intervention not only significantly reduced body weight (-1.72 ± 1.83 kg, P < 0.001), but also remarkably improved glycemic control, with reduced glycated hemoglobin (HbA1c; -0.69 % ± 0.48 %, P < 0.001) and fasting blood glucose (-0.90 ± 1.27 mmol/L, P = 0.008) levels. In addition, TRE also significantly reduced triglyceride level (-0.26 mmol/L [-0.52 to -0.04 mmol/L], P = 0.004) and fatty liver index (-8.64 [-15.4 to -2.87], P = 0.003) after 12 weeks of intervention. Notably, the benefits for HbA1c reduction lasted for up to 1 year. TRE can improve glycemic control up to 1 year in individuals with type 2 diabetes. Our findings indicate that TRE may represent a novel diet management option for patients with type 2 diabetes.
1 July 2020 in American Journal of Infection Control